Fundraising FoxHemosphere
4 known investors
Find your way into Hemosphere
Sign up to see every warm intro you have to Hemosphere
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hemosphere team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HeRO Graft is a fully subcutaneous arteriovenous access device for hemodialysis patients with central venous stenosis, designed to reduce infection rates and improve long-term vascular access reliability. The product combines an ePTFE arterial graft component with a silicone venous outflow component for dialysis treatment.
Investors · 4
How we know: Emergent Medical Partners, LLP's portfolio page · Not right? Tell us
How we know: Mutual Capital Partners's portfolio page · funding news · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Hemosphere do?
- HeRO Graft is a fully subcutaneous arteriovenous access device for hemodialysis patients with central venous stenosis, designed to reduce infection rates and improve long-term vascular access reliability. The product combines an ePTFE arterial graft component with a silicone venous outflow component for dialysis treatment.
- Who are Hemosphere's investors?
- Hemosphere's investors include Emergent Medical Partners, LLP, Mutual Capital Partners, Ascension Ventures, Kaiser Permanente Ventures.